Stay updated on Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A site version tag was updated from v3.6.4 to v3.6.5, reflecting a routine platform version update.
    Difference
    0.1%
    Check dated 2026-08-08T15:18:40.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page received a deployment update to revision v3.6.4, replacing the prior v3.6.3. This likely includes minor fixes or refinements to the site’s behavior or layout without altering study content.
    Difference
    0.1%
    Check dated 2026-07-25T08:20:28.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.3, indicating a minor platform update to the page hosting the study record. No study content or results are affected.
    Difference
    0.1%
    Check dated 2026-07-03T22:14:02.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, indicating a newer build of the interface. This change does not modify any study details or user-facing interactions.
    Difference
    0.1%
    Check dated 2026-06-26T23:54:37.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The study page adds a recruitment status note ('No longer looking for participants') and new help links (How to Read a Study Record, Common Questions, How to Join a Study), while updating the Intervention/Treatment label from 'Intervention / Treatment' to 'Intervention/Treatment' and including a site revision marker ('Revision: v3.6.0').
    Difference
    0.4%
    Check dated 2026-06-12T16:46:53.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the previous v3.5.4 on the page, signaling a new version of the page's content or template. This update does not change the study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-06-05T12:23:31.000Z thumbnail image

Stay in the know with updates to Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.